(Q40133774)

17 September 2017

1 reference

title

Cardiovascular consequences of endogenous opiate antagonism (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

20 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

20 September 2023

author name string

J. W. Holaday

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6299300

20 September 2023

language of work or name

English

0 references

publication date

1 February 1983

1 reference

17 September 2017

15 February 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6299300

full work available at URL

20 September 2023

https://api.elsevier.com/content/article/PII:0006295283904793?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

https://api.elsevier.com/content/article/PII:0006295283904793?httpAccept=text/plain

20 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

20 September 2023

published in

Biochemical Pharmacology

1 reference

17 September 2017

32

1 reference

17 September 2017

4

1 reference

17 September 2017

573-585

1 reference

EFFECT OF SOME BLOCKING DRUGS ON THE PRESSOR RESPONSE TO PHYSOSTIGMINE IN THE RAT

17 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

The fall of blood pressure caused by intravenous morphine in the rat and the cat.

20 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Cardiovascular effects of intravenous morphine in the anaesthetized rat

20 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine liberators

20 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Enhancement of nociceptive reactions by naloxone in mice and rats (author's transl)

20 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland

20 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Endogenous opioid peptides: multiple agonists and receptors

20 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Multiple opioid receptors

20 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat

20 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system

20 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues

20 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla

20 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Opioid Receptors Undergo Axonal Flow

20 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Neurophysiology and neuropharmacology of cardiovascular regulation and stress

20 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem

20 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock

20 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Mechanisms of the hemodynamic effects of endotoxin

20 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Acidosis lowers in-vivo potency of narcotics and narcotic antagonists and can even abolish narcotic antagonist activity

20 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Ventriculocisternal administration of naloxone protects against severe hypotension during endotoxin shock

20 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Opiate antagonists: a role in the treatment of hypovolemic shock

20 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Reversal by naloxone of hemorrhagic shock in anephric cats

20 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

American Journal of Physiology

20 September 2023

57

239

H416

Curtis

1980

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

American Journal of Physiology

20 September 2023

59

241

H479

Holaday

1981

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Effect of naloxone on the cardiovascular and sympathetic response to hypovolemic hypotension in the rat

20 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock

20 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Endorphin-parasympathetic interaction in spinal shock

20 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

DEPRESSION OF VENTRICULAR CONTRACTILITY BY STIMULATION OF THE VAGUS NERVES

20 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Beneficial action of naloxone in splanchnic artery occlusion shock

20 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury

20 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Naloxone attenuates the hypotension induced by Hageman factor

20 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Effect of naloxone, a specific opioid inhibitor, on blood pressure fall during sleep.

20 September 2023

75

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia

20 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Naloxone reverses the antihypertensive effect of clonidine

20 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

α-Adrenergic Stimulation by Clonidine Increases Plasma Concentrations of Immunoreactive β-Endorphin in Rats

20 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Central peptidergic stimulation in blood pressure control: role of enkephalins in rats

20 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Effects of intravenously administered Leu- or Met-enkephalin on arterial blood pressure

20 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Cardiopulmonary pharmacology of enkephalins in the conscious dog

20 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats

20 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats

20 September 2023

88

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats

20 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Brain Opiate Receptor Concentrations are Increased in Adult Spontaneously Hypertensive Rats

20 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex

20 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Baroreceptor activation reduces reactivity to noxious stimulation: implications for hypertension

20 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate

20 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Opiate analogs, substance P, and baroreceptor reflexes in the rabbit

20 September 2023

95

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Perfusion of the fourth cerebral ventricle with fentanyl induces naloxone-reversible bradycardia, hypotension, and EEG synchronisation in conscious dogs

20 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Potentiation by naloxone of pressor reflexes

20 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Opiate antagonist improves neurologic recovery after spinal injury

20 September 2023

98

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Endorphins in experimental spinal injury: Therapeutic effect of naloxone

20 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Effect of naloxone on posttraumatic ischemia in experimental spinal contusion

20 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke".

20 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Reversal of Induced Ischemic Neurologic Deficit in Gerbils by the Opiate Antagonist Naloxone

20 September 2023

103

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

NALOXONE REVERSAL OF ISCHAEMIC NEUROLOGICAL DEFICITS IN MAN

20 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.

20 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Thyrotropin releasing hormone antagonizes β endorphin hypothermia and catalepsy

20 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Effects of thyrotropin-releasing hormone on behavioral and hormonal changes induced by β-endorphin

20 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock

20 September 2023

108

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock

20 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats

20 September 2023

111

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

M 154,129, a putative delta antagonist, reverses endotoxic shock without altering morphine analgesia

20 September 2023

113

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Experimental Endotoxin Shock: The Pathophysiologic Function of Endorphins and Treatment with Opiate Antagonists

20 September 2023

115

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Naloxone in irreversible shock

20 September 2023

117

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Pressor effect of naloxone in septic shock

20 September 2023

118

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

20 September 2023

Naloxone in shock

119

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

Response to naloxone in septic shock

20 September 2023

120

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90479-3

20 September 2023

Identifiers

1 reference

17 September 2017

1 reference